fda label

valsartan + potassium

Valsartan is an angiotensin II receptor blocker that suppresses aldosterone and slows renal potassium excretion. The FDA-approved Diovan label specifically warns that potassium supplements and potassium-containing salt substitutes may lead to clinically significant hyperkalemia, particularly in patients with renal impairment, diabetes, or heart failure.